DIN 02562782 — NILEMDO 180 MG
NILEMDO is a tablet of Bempedoic acid marketed by HLS THERAPEUTICS INC. The full Bempedoic acid monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02562782
- Brand name
- NILEMDO
- Active ingredient
- Bempedoic acid
- Strength
- 180 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- HLS THERAPEUTICS INC
- Health Canada status
- MARKETED
- Drug class
- ATP-citrate lyase (ACL) inhibitor (lipid metabolism regulator)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.